Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib
>> article
AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib
Editor:xuezhe Clicks:
0
Date:2022-6-26 15:46:11
Keyword:
AstraZeneca
Healthoo Information:
AstraZeneca Merck Jointly Release the Results of the Phase 3 Clinical Trial of Olaparib
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Phase III Study of AstraZenecas Innovative Therapy was Successful! A L...
AstraZeneca is Considering Buying Its Partner Mereo BioPharma
AstraZeneca adjusted business strategy in China
AstraZeneca started to build manufacturing fa...
AstraZeneca to acquire a generics company&nbs...
AstraZeneca to build new manufacturing facili...
AstraZeneca begins construction work at Zhang...
AstraZeneca planned to built a industry ...
AstraZeneca Outsources to China
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
